150 related articles for article (PubMed ID: 20628088)
1. Maternally transmitted and food-derived glycotoxins: a factor preconditioning the young to diabetes?
Mericq V; Piccardo C; Cai W; Chen X; Zhu L; Striker GE; Vlassara H; Uribarri J
Diabetes Care; 2010 Oct; 33(10):2232-7. PubMed ID: 20628088
[TBL] [Abstract][Full Text] [Related]
2. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging.
Uribarri J; Cai W; Peppa M; Goodman S; Ferrucci L; Striker G; Vlassara H
J Gerontol A Biol Sci Med Sci; 2007 Apr; 62(4):427-33. PubMed ID: 17452738
[TBL] [Abstract][Full Text] [Related]
3. Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients.
Uribarri J; Peppa M; Cai W; Goldberg T; Lu M; Baliga S; Vassalotti JA; Vlassara H
Am J Kidney Dis; 2003 Sep; 42(3):532-8. PubMed ID: 12955681
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products in infant formulas do not contribute to insulin resistance associated with their consumption.
Klenovics KS; Boor P; Somoza V; Celec P; Fogliano V; Sebeková K
PLoS One; 2013; 8(1):e53056. PubMed ID: 23301020
[TBL] [Abstract][Full Text] [Related]
5. The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes.
Barzilay JI; Jablonski KA; Fonseca V; Shoelson SE; Goldfine AB; Strauch C; Monnier VM;
Diabetes Care; 2014 Apr; 37(4):1083-91. PubMed ID: 24255104
[TBL] [Abstract][Full Text] [Related]
6. Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial.
Kellow NJ; Coughlan MT; Savige GS; Reid CM
BMC Endocr Disord; 2014 Jul; 14():55. PubMed ID: 25011647
[TBL] [Abstract][Full Text] [Related]
7. Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial.
de Courten B; de Courten MP; Soldatos G; Dougherty SL; Straznicky N; Schlaich M; Sourris KC; Chand V; Scheijen JL; Kingwell BA; Cooper ME; Schalkwijk CG; Walker KZ; Forbes JM
Am J Clin Nutr; 2016 Jun; 103(6):1426-33. PubMed ID: 27030534
[TBL] [Abstract][Full Text] [Related]
8. Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men.
Lamb LS; Alfonso H; Norman PE; Davis TME; Forbes J; Müench G; Irrgang F; Almeida OP; Golledge J; Hankey GJ; Flicker L; Yeap BB
J Clin Endocrinol Metab; 2018 Nov; 103(11):4224-4231. PubMed ID: 30137355
[TBL] [Abstract][Full Text] [Related]
9. Dietary intake increases serum levels of carboxymethil-lysine (CML) in diabetic patients.
Jara N; Leal MJ; Bunout D; Hirsch S; Barrera G; Leiva L; de la Maza MP
Nutr Hosp; 2012; 27(4):1272-8. PubMed ID: 23165573
[TBL] [Abstract][Full Text] [Related]
10. Endothelial Dysfunction and Advanced Glycation End Products in Patients with Newly Diagnosed Versus Established Diabetes: From the CORDIOPREV Study.
de la Cruz-Ares S; Cardelo MP; Gutiérrez-Mariscal FM; Torres-Peña JD; García-Rios A; Katsiki N; Malagón MM; López-Miranda J; Pérez-Martínez P; Yubero-Serrano EM
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963378
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.
Esmaeili F; Maleki V; Kheirouri S; Alizadeh M
Can J Diabetes; 2021 Feb; 45(1):39-46. PubMed ID: 32861603
[TBL] [Abstract][Full Text] [Related]
12. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy.
Koschinsky T; He CJ; Mitsuhashi T; Bucala R; Liu C; Buenting C; Heitmann K; Vlassara H
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6474-9. PubMed ID: 9177242
[TBL] [Abstract][Full Text] [Related]
13. Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice.
Peppa M; He C; Hattori M; McEvoy R; Zheng F; Vlassara H
Diabetes; 2003 Jun; 52(6):1441-8. PubMed ID: 12765955
[TBL] [Abstract][Full Text] [Related]
14. Changes in circulating levels of carboxymethyllysine, soluble receptor for advanced glycation end products (sRAGE), and inflammation markers in women during normal pregnancy.
Quintanilla-García CV; Uribarri J; Fajardo-Araujo ME; Barrientos-Romero JJ; Romero-Gutiérrez G; Reynaga-Ornelas MG; Garay-Sevilla ME
J Matern Fetal Neonatal Med; 2019 Dec; 32(24):4102-4107. PubMed ID: 29804482
[No Abstract] [Full Text] [Related]
15. A Retrospective Study in Adults with Metabolic Syndrome: Diabetic Risk Factor Response to Daily Consumption of Agaricus bisporus (White Button Mushrooms).
Calvo MS; Mehrotra A; Beelman RB; Nadkarni G; Wang L; Cai W; Goh BC; Kalaras MD; Uribarri J
Plant Foods Hum Nutr; 2016 Sep; 71(3):245-51. PubMed ID: 27193019
[TBL] [Abstract][Full Text] [Related]
16. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA.
Galler A; Müller G; Schinzel R; Kratzsch J; Kiess W; Münch G
Diabetes Care; 2003 Sep; 26(9):2609-15. PubMed ID: 12941727
[TBL] [Abstract][Full Text] [Related]
17. Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study.
Sveen KA; Karimé B; Jørum E; Mellgren SI; Fagerland MW; Monnier VM; Dahl-Jørgensen K; Hanssen KF
Diabetes Care; 2013 Nov; 36(11):3712-7. PubMed ID: 24026557
[TBL] [Abstract][Full Text] [Related]
18. Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics Study.
Semba RD; Ang A; Talegawkar S; Crasto C; Dalal M; Jardack P; Traber MG; Ferrucci L; Arab L
Eur J Clin Nutr; 2012 Jan; 66(1):3-9. PubMed ID: 21792213
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake.
Sandu O; Song K; Cai W; Zheng F; Uribarri J; Vlassara H
Diabetes; 2005 Aug; 54(8):2314-9. PubMed ID: 16046296
[TBL] [Abstract][Full Text] [Related]
20. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1.
Uribarri J; Cai W; Ramdas M; Goodman S; Pyzik R; Chen X; Zhu L; Striker GE; Vlassara H
Diabetes Care; 2011 Jul; 34(7):1610-6. PubMed ID: 21709297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
